Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Fibrocyte accumulation in the airway walls of COPD patients.

Dupin I, Thumerel M, Maurat E, Coste F, Eyraud E, Begueret H, Trian T, Montaudon M, Marthan R, Girodet PO, Berger P.

Eur Respir J. 2019 Sep 5;54(3). pii: 1802173. doi: 10.1183/13993003.02173-2018. Print 2019 Sep.

PMID:
31196946
2.

Automated Volumetric Quantification of Emphysema Severity by Using Ultrashort Echo Time MRI: Validation in Participants with Chronic Obstructive Pulmonary Disease.

Benlala I, Berger P, Girodet PO, Dromer C, Macey J, Laurent F, Dournes G.

Radiology. 2019 Jul;292(1):216-225. doi: 10.1148/radiol.2019190052. Epub 2019 Jun 4.

PMID:
31161972
3.

Monitoring of drug misuse or potential misuse in a nationwide healthcare insurance database: A cross-sectional study in France.

Bénard-Laribière A, Noize P, Girodet PO, Lassalle R, Dureau-Pournin C, Droz-Perroteau C, Fourrier-Réglat A, Salvo F, Bezin J, Pariente A; DRUGS-2M study group.

Therapie. 2019 Sep;74(4):469-476. doi: 10.1016/j.therap.2018.12.007. Epub 2018 Dec 30.

PMID:
30857740
4.

Quantitative CT assessment of bronchial and vascular alterations in severe precapillary pulmonary hypertension.

Coste F, Benlala I, Dournes G, Dromer C, Blanchard E, Girodet PO, Montaudon M, Baldacci F, Picard F, Marthan R, Laurent F, Berger P.

Int J Chron Obstruct Pulmon Dis. 2019 Feb 11;14:381-389. doi: 10.2147/COPD.S177638. eCollection 2019.

5.

Interest of pharmacoepidemiology for the study of inhaled drugs.

Molimard M, Girodet PO, Van Ganse E.

Therapie. 2019 Apr;74(2):233-237. doi: 10.1016/j.therap.2018.08.002. Epub 2018 Oct 19.

PMID:
30392699
6.

Inhaled triple therapy in chronic obstructive pulmonary disease.

Molimard M, Girodet PO, Moore N.

Lancet. 2018 Sep 29;392(10153):1112. doi: 10.1016/S0140-6736(18)31798-7. No abstract available.

PMID:
30303074
7.

Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow Limitation.

Silkoff PE, Singh D, FitzGerald JM, Eich A, Ludwig-Sengpiel A, Chupp GC, Backer V, Porsbjerg C, Girodet PO, Dransfield MT, Baribaud F, Susulic VS, Loza MJ.

Biomark Insights. 2017 Sep 7;12:1177271917730306. doi: 10.1177/1177271917730306. eCollection 2017.

8.

Efficacy and safety of indacaterol in patients with chronic obstructive pulmonary disease aged over 65 years: A pooled analysis.

Girodet PO, Jasnot JY, Le Gros V, Decuypère L, Cao W, Devouassoux G.

Respir Med. 2017 Jul;128:92-101. doi: 10.1016/j.rmed.2017.05.010. Epub 2017 May 24.

9.

Chronic obstructive pulmonary disease exacerbation and inhaler device handling: real-life assessment of 2935 patients.

Molimard M, Raherison C, Lignot S, Balestra A, Lamarque S, Chartier A, Droz-Perroteau C, Lassalle R, Moore N, Girodet PO.

Eur Respir J. 2017 Feb 15;49(2). pii: 1601794. doi: 10.1183/13993003.01794-2016. Print 2017 Feb.

10.

Identification of airway mucosal type 2 inflammation by using clinical biomarkers in asthmatic patients.

Silkoff PE, Laviolette M, Singh D, FitzGerald JM, Kelsen S, Backer V, Porsbjerg CM, Girodet PO, Berger P, Kline JN, Chupp G, Susulic VS, Barnathan ES, Baribaud F, Loza MJ; Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study investigators.

J Allergy Clin Immunol. 2017 Sep;140(3):710-719. doi: 10.1016/j.jaci.2016.11.038. Epub 2017 Jan 13.

PMID:
28089872
11.

Effectiveness of Fluticasone Furoate-Vilanterol in COPD.

Girodet PO, Raherison Ch, Molimard M.

N Engl J Med. 2016 Dec 29;375(26):2605-6. No abstract available.

PMID:
28032960
12.

Alternative Macrophage Activation Is Increased in Asthma.

Girodet PO, Nguyen D, Mancini JD, Hundal M, Zhou X, Israel E, Cernadas M.

Am J Respir Cell Mol Biol. 2016 Oct;55(4):467-475.

13.

Longitudinal stability of asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) study.

Silkoff PE, Laviolette M, Singh D, FitzGerald JM, Kelsen S, Backer V, Porsbjerg C, Girodet PO, Berger P, Kline JN, Khatri S, Chanez P, Susulic VS, Barnathan ES, Baribaud F, Loza MJ; ADEPT Investigators.

Respir Res. 2016 Apr 23;17:43. doi: 10.1186/s12931-016-0360-5.

14.

CT evaluation of small pulmonary vessels area in patients with COPD with severe pulmonary hypertension.

Coste F, Dournes G, Dromer C, Blanchard E, Freund-Michel V, Girodet PO, Montaudon M, Baldacci F, Picard F, Marthan R, Berger P, Laurent F.

Thorax. 2016 Sep;71(9):830-7. doi: 10.1136/thoraxjnl-2015-207696. Epub 2016 Apr 15.

PMID:
27084957
15.

Reply.

Dupin I, Girodet PO, Berger P.

J Allergy Clin Immunol. 2016 May;137(5):1626. doi: 10.1016/j.jaci.2016.01.022. Epub 2016 Mar 22. No abstract available.

PMID:
27012640
16.

Quiet Submillimeter MR Imaging of the Lung Is Feasible with a PETRA Sequence at 1.5 T.

Dournes G, Grodzki D, Macey J, Girodet PO, Fayon M, Chateil JF, Montaudon M, Berger P, Laurent F.

Radiology. 2016 Apr;279(1):328. doi: 10.1148/radiol.2016164006. No abstract available.

PMID:
26989938
17.

Vitamin D3 treatment of vitamin D-insufficient asthmatic patients does not alter immune cell function.

Reid B, Girodet PO, Boomer JS, Abdel-Gadir A, Zheng K, Wechsler ME, Bacharier LB, Kunselman SJ, King TS, Israel E, Castro M, Cernadas M, Green JM.

J Allergy Clin Immunol. 2016 Jul;138(1):286-289.e9. doi: 10.1016/j.jaci.2015.11.030. Epub 2016 Feb 10. No abstract available.

18.

Selective dysfunction of p53 for mitochondrial biogenesis induces cellular proliferation in bronchial smooth muscle from asthmatic patients.

Trian T, Allard B, Ozier A, Maurat E, Dupin I, Thumerel M, Ousova O, Gillibert-Duplantier J, Le Morvan V, Begueret H, Girodet PO, Marthan R, Berger P.

J Allergy Clin Immunol. 2016 Jun;137(6):1717-1726.e13. doi: 10.1016/j.jaci.2015.10.031. Epub 2015 Dec 11.

PMID:
26688517
19.

Blood fibrocytes are recruited during acute exacerbations of chronic obstructive pulmonary disease through a CXCR4-dependent pathway.

Dupin I, Allard B, Ozier A, Maurat E, Ousova O, Delbrel E, Trian T, Bui HN, Dromer C, Guisset O, Blanchard E, Hilbert G, Vargas F, Thumerel M, Marthan R, Girodet PO, Berger P.

J Allergy Clin Immunol. 2016 Apr;137(4):1036-1042.e7. doi: 10.1016/j.jaci.2015.08.043. Epub 2015 Oct 23.

PMID:
26602164
20.

Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study.

Silkoff PE, Strambu I, Laviolette M, Singh D, FitzGerald JM, Lam S, Kelsen S, Eich A, Ludwig-Sengpiel A, Hupp GC, Backer V, Porsbjerg C, Girodet PO, Berger P, Leigh R, Kline JN, Dransfield M, Calhoun W, Hussaini A, Khatri S, Chanez P, Susulic VS, Barnathan ES, Curran M, Das AM, Brodmerkel C, Baribaud F, Loza MJ.

Respir Res. 2015 Nov 17;16:142. doi: 10.1186/s12931-015-0299-y.

21.

Bronchial Smooth Muscle Remodeling in Nonsevere Asthma.

Girodet PO, Allard B, Thumerel M, Begueret H, Dupin I, Ousova O, Lassalle R, Maurat E, Ozier A, Trian T, Marthan R, Berger P.

Am J Respir Crit Care Med. 2016 Mar 15;193(6):627-33. doi: 10.1164/rccm.201507-1404OC.

PMID:
26540234
22.

Choice of ICD-10 codes for the identification of acute coronary syndrome in the French hospitalization database.

Bezin J, Girodet PO, Rambelomanana S, Touya M, Ferreira P, Gilleron V, Robinson P, Moore N, Pariente A.

Fundam Clin Pharmacol. 2015 Dec;29(6):586-91. doi: 10.1111/fcp.12143. Epub 2015 Sep 15.

PMID:
26301735
23.

Quiet Submillimeter MR Imaging of the Lung Is Feasible with a PETRA Sequence at 1.5 T.

Dournes G, Grodzki D, Macey J, Girodet PO, Fayon M, Chateil JF, Montaudon M, Berger P, Laurent F.

Radiology. 2015 Jul;276(1):258-65. doi: 10.1148/radiol.15141655. Epub 2015 Mar 13. Erratum in: Radiology. 2016 Apr;279(1):328.

PMID:
25768672
24.

Calcium channel blocker reduces airway remodeling in severe asthma. A proof-of-concept study.

Girodet PO, Dournes G, Thumerel M, Begueret H, Dos Santos P, Ozier A, Dupin I, Trian T, Montaudon M, Laurent F, Marthan R, Berger P.

Am J Respir Crit Care Med. 2015 Apr 15;191(8):876-83. doi: 10.1164/rccm.201410-1874OC.

PMID:
25633090
25.

House dust mites induce proliferation of severe asthmatic smooth muscle cells via an epithelium-dependent pathway.

Trian T, Allard B, Dupin I, Carvalho G, Ousova O, Maurat E, Bataille J, Thumerel M, Begueret H, Girodet PO, Marthan R, Berger P.

Am J Respir Crit Care Med. 2015 Mar 1;191(5):538-46. doi: 10.1164/rccm.201409-1582OC.

PMID:
25569771
26.

Computed tomographic measurement of airway remodeling and emphysema in advanced chronic obstructive pulmonary disease. Correlation with pulmonary hypertension.

Dournes G, Laurent F, Coste F, Dromer C, Blanchard E, Picard F, Baldacci F, Montaudon M, Girodet PO, Marthan R, Berger P.

Am J Respir Crit Care Med. 2015 Jan 1;191(1):63-70. doi: 10.1164/rccm.201408-1423OC.

PMID:
25393421
27.

Protease activated receptor-2 expression and function in asthmatic bronchial smooth muscle.

Allard B, Bara I, Gilbert G, Carvalho G, Trian T, Ozier A, Gillibert-Duplantier J, Ousova O, Maurat E, Thumerel M, Quignard JF, Girodet PO, Marthan R, Berger P.

PLoS One. 2014 Feb 13;9(2):e86945. doi: 10.1371/journal.pone.0086945. eCollection 2014.

28.

Comparison of Mycoplasma pneumoniae Infections in asthmatic children versus asthmatic adults.

Bébéar C, Raherison C, Nacka F, de Barbeyrac B, Pereyre S, Renaudin H, Girodet PO, Marquant F, Desjardins S, Chêne G, Fayon M.

Pediatr Infect Dis J. 2014 Mar;33(3):e71-5. doi: 10.1097/INF.0000000000000063.

PMID:
24030350
29.

A proof-of-concept, randomized, controlled trial of omalizumab in patients with severe, difficult-to-control, nonatopic asthma.

Garcia G, Magnan A, Chiron R, Contin-Bordes C, Berger P, Taillé C, Devouassoux G, de Blay F, Couderc LJ, Didier A, O'Callaghan DS, Girodet PO, Bourdeix I, Le Gros V, Humbert M.

Chest. 2013 Aug;144(2):411-419. doi: 10.1378/chest.12-1961.

PMID:
23579324
30.

Ca(2+)-activated K(+) channel-3.1 blocker TRAM-34 attenuates airway remodeling and eosinophilia in a murine asthma model.

Girodet PO, Ozier A, Carvalho G, Ilina O, Ousova O, Gadeau AP, Begueret H, Wulff H, Marthan R, Bradding P, Berger P.

Am J Respir Cell Mol Biol. 2013 Feb;48(2):212-9. doi: 10.1165/rcmb.2012-0103OC. Epub 2012 Nov 29.

31.

In vivo micro-CT assessment of airway remodeling in a flexible OVA-sensitized murine model of asthma.

Lederlin M, Ozier A, Dournes G, Ousova O, Girodet PO, Begueret H, Marthan R, Montaudon M, Laurent F, Berger P.

PLoS One. 2012;7(10):e48493. doi: 10.1371/journal.pone.0048493. Epub 2012 Oct 30.

32.

Factors associated with serious traffic crashes: a prospective study in southwest France.

Blazejewski S, Girodet PO, Orriols L, Capelli A, Moore N; CESIR Group.

Arch Intern Med. 2012 Jul 9;172(13):1039-41. doi: 10.1001/archinternmed.2012.1695. No abstract available.

PMID:
22641170
33.

[Asthma exacerbations: pharmacological prevention].

Grassin-Delyle S, Girodet PO.

Rev Mal Respir. 2012 Feb;29(2):232-44. doi: 10.1016/j.rmr.2011.05.018. Epub 2012 Jan 9. Review. French.

PMID:
22405116
34.

Role of YKL-40 in bronchial smooth muscle remodeling in asthma.

Bara I, Ozier A, Girodet PO, Carvalho G, Cattiaux J, Begueret H, Thumerel M, Ousova O, Kolbeck R, Coyle AJ, Woods J, Tunon de Lara JM, Marthan R, Berger P.

Am J Respir Crit Care Med. 2012 Apr 1;185(7):715-22. doi: 10.1164/rccm.201105-0915OC. Epub 2012 Jan 26.

PMID:
22281830
35.

The pivotal role of airway smooth muscle in asthma pathophysiology.

Ozier A, Allard B, Bara I, Girodet PO, Trian T, Marthan R, Berger P.

J Allergy (Cairo). 2011;2011:742710. doi: 10.1155/2011/742710. Epub 2011 Dec 11.

36.

[Pathophysiology of asthma].

Ozier A, Bara I, Girodet PO, Marthan R, Berger P.

Rev Prat. 2011 Mar;61(3):339-45. French.

PMID:
21563408
37.

Airway remodeling in asthma: new mechanisms and potential for pharmacological intervention.

Girodet PO, Ozier A, Bara I, Tunon de Lara JM, Marthan R, Berger P.

Pharmacol Ther. 2011 Jun;130(3):325-37. doi: 10.1016/j.pharmthera.2011.02.001. Epub 2011 Feb 17. Review.

PMID:
21334378
38.

Control maintenance can be predicted by exhaled NO monitoring in asthmatic patients.

Ozier A, Girodet PO, Bara I, Tunon de Lara JM, Marthan R, Berger P.

Respir Med. 2011 Jul;105(7):989-96. doi: 10.1016/j.rmed.2011.01.006. Epub 2011 Feb 3.

39.

Epidemiology of COPD.

Raherison C, Girodet PO.

Eur Respir Rev. 2009 Dec;18(114):213-21. doi: 10.1183/09059180.00003609. Review.

40.

Mast cell adhesion to bronchial smooth muscle in asthma specifically depends on CD51 and CD44 variant 6.

Girodet PO, Ozier A, Trian T, Begueret H, Ousova O, Vernejoux JM, Chanez P, Marthan R, Berger P, Tunon de Lara JM.

Allergy. 2010 Aug;65(8):1004-12. doi: 10.1111/j.1398-9995.2009.02308.x. Epub 2010 Feb 1.

PMID:
20121756
41.

Phytalgic, a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial.

Jacquet A, Girodet PO, Pariente A, Forest K, Mallet L, Moore N.

Arthritis Res Ther. 2009;11(6):R192. doi: 10.1186/ar2891. Epub 2009 Dec 16.

42.

The chronic oral administration of arginine aspartate decreases secretion of IGF-1 and IGFBP-3 in healthy volunteers.

Blazejewski S, Georges A, Forest K, Corcuff JB, Abouelfath A, Girodet PO, Kamagate M, Jacquet A, Pillet O, Bordenave L, Moore N.

Fundam Clin Pharmacol. 2009 Jun;23(3):339-44. doi: 10.1111/j.1472-8206.2009.00716.x.

PMID:
19527301
43.

Drug interactions between inhaled corticosteroids and enzymatic inhibitors.

Daveluy A, Raignoux C, Miremont-Salamé G, Girodet PO, Moore N, Haramburu F, Molimard M.

Eur J Clin Pharmacol. 2009 Jul;65(7):743-5. doi: 10.1007/s00228-009-0653-4. Epub 2009 Apr 28. No abstract available.

PMID:
19399485
44.

Inhaled corticosteroids and adrenal insufficiency: prevalence and clinical presentation.

Molimard M, Girodet PO, Pollet C, Fourrier-Réglat A, Daveluy A, Haramburu F, Fayon M, Tabarin A.

Drug Saf. 2008;31(9):769-74.

PMID:
18707191
45.

Multi-professional lung cancer disclosure to change anxiety and depression: an exploratory study.

Cousson-Gélie F, Vernejoux JM, Bazex-Chanteloube H, Raherison C, Ozier A, Girodet PO, Taytard A.

Thorax. 2008 Jul;63(7):658. doi: 10.1136/thx.2007.093922. No abstract available.

PMID:
18587039
46.

[What is the therapeutic response to corticosteroid in smokers with asthma?].

Girodet PO.

Rev Mal Respir. 2008 Feb;25(2):185-92. Review. French.

PMID:
18449080
47.

Bronchial smooth muscle remodeling involves calcium-dependent enhanced mitochondrial biogenesis in asthma.

Trian T, Benard G, Begueret H, Rossignol R, Girodet PO, Ghosh D, Ousova O, Vernejoux JM, Marthan R, Tunon-de-Lara JM, Berger P.

J Exp Med. 2007 Dec 24;204(13):3173-81. Epub 2007 Dec 3.

48.

Fraktalkine produced by airway smooth muscle cells contributes to mast cell recruitment in asthma.

El-Shazly A, Berger P, Girodet PO, Ousova O, Fayon M, Vernejoux JM, Marthan R, Tunon-de-Lara JM.

J Immunol. 2006 Feb 1;176(3):1860-8.

49.

[IgE and respiratory disease].

Girodet PO, Casset A, Magnan A, de Blay F, Chanez P, Tunon De Lara JM.

Rev Mal Respir. 2005 Dec;22(6 Pt 1):967-81. Review. French.

PMID:
16249755
50.

RNA interference decreases PAR-2 expression and function in human airway smooth muscle cells.

Trian T, Girodet PO, Ousova O, Marthan R, Tunon-de-Lara JM, Berger P.

Am J Respir Cell Mol Biol. 2006 Jan;34(1):49-55. Epub 2005 Sep 29.

PMID:
16195539

Supplemental Content

Loading ...
Support Center